Live Attenuated Varicella Virus Vaccine: Efficacy Trial in Healthy Children

New England Journal of Medicine

Volumn 310, Issue 22, 1984, Pages 1409-1415

  Weibel, Robert E ^a,b   Neff, Beverly J ^a,b   Kuter, Barbara J ^a,b   Guess, Harry A ^a,b   Rothenberger, Carol A ^a,b   Fitzgerald, Alison J ^a,b   Connor, Karen A ^a,b   Mclean, Arlene A ^a,b   Hilleman, Maurice R ^a,b   Buynak, Eugene B ^a,b   Scolnick, Edward M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; LIVE VACCINE; PLACEBO; VACCINE; VIRUS ANTIBODY;

ADVERSE DRUG REACTION; ANOREXIA; ANTIBODY PRODUCTION; ANTIBODY TITER; CHILD; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG THERAPY; ERYTHEMA; FEVER; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INJECTION PAIN; INSOMNIA; INTOXICATION; IRRITABILITY; MAJOR CLINICAL STUDY; PREVENTION; RASH; SKIN TOXICITY; THERAPY; VARICELLA ZOSTER VIRUS;

EID: 0021256109     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198405313102201     Document Type: Article

References (32)

1. Weller TH. Varicella-herpes zoster virus. In: Evans AA, ed. Viral infections of humans: epidemiology and control. 2nd ed. New York: Plenum, 1982:569–95.
2. Preblud SR. Age specific risks of varicella complications. Pediatrics 1981; 68: 14–7.
3. Fleisher G, Henry W, McSorley M, Arbeter A, Plotkin S. Life-threatening complications of varicella. Am J Dis Child 1981; 135: 896–9.
4. Guess HA, Broughton DD, Melton LJ, Kurland LT. Chickenpox hospital izations in residents of Olmsted County, Minnesota 1962–1981: a population-based study. Am J Dis Child (in press).
5. Gershon AA, Raker R, Steinberg S, Topf-Olstein B, Drusin LM. Antibody to varicella–zoster virus in parturient women and their offspring during the first year of life. Pediatrics 1976; 58: 692–6.
6. Steiner W. Zur Inokulation der Varicellen. Wien Med Wochenschr 1875; 16: 306.
7. Greenthal RM. The prophylaxis of varicella with vesicle fluid. Am J Dis Child 1926; 31: 851–5.
8. Iovlev VI, Boichuk LM, Kuzmicheva AT, Ivanova MV, Smorodintsev AA. Reactogenic and immunogenic properties of an attenuated strain of chickenpox virus. Vopr Virusol 1969; 14: 561–5. (Russian).
9. Neff BJ, Weihel RE, Villarejos VM, et al. Clinical and laboratory studies of KMcC strain live attenuated varicella virus. Proc Soc Exp Biol Med 1981; 166: 339–47.
10. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974; 2: 1288–90.
11. Arbeter AM, Starr SE, Weibel RE, Neff BJ, Plotkin SA. Live attenuated varicella vaccine: the KMcC strain in healthy children. Pediatrics 1983; 71: 307–12.
12. Hediard B, Burguiere AM, Devillechabrolle A, et al. Etude preliminaire d'un vaccin varicelle-zona attenue (souche Webster) chez 27 enfants sans troubles immunitaires. Ann Pediatr 1983; 30: 440–44.
13. Arbeter AM, Starr SE, Weibel RE, Plotkin SA. Live attenuated varicella vaccine: immunization of healthy children with the OKA strain. J Pediatr 1982; 100: 886–93.
14. Asano Y, Hirose S, Iwayama S, Miyata T, Yazaki T, Takahashi M. Protective effect of immediate inoculation of a live varicella vaccine in household contacts in relation to the viral dose and interval between exposure and vaccination. Biken J 1982; 25: 43–5.
15. Asano Y, Nakayama H, Yazaki T, Ito S, Isomura S, Takahashi M. Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward. Pediatrics 1977; 59: 8–12.
16. Asano Y, Nakayama H, Yazaki T, et al. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics 1977; 59: 3–7.
17. Ha K, Baba K, Ikeda T, et al. Application of live varicella vaccine to children with acute leukemia or other malignancies without suspension of anticancer therapy. Pediatrics 1980; 65: 346–50.
18. Ueda K, Yamada I, Goto M, et al. Use of a live varicella vaccine to prevent the spread of varicella in handicapped or immunosuppressed children including MCLS (muco-cutaneous lymphnode syndrome) patients in hospitals. Biken J 1977; 20: 117–23.
19. Brunell PA, Shehab Z, Geiser C, Waugh JE. Administration of live varicella vaccine to children with leukaemia. Lancet 1982; 2: 1069–73.
20. Code of Federal Regulations. Title 21. Food and Drugs, Parts 600–1299. Washington, D.C.: Government Printing Office, April 1981. (Special Edition of the Federal Register).
21. Gershon AA, Kalter ZG, Steinberg S. Detection of antibody to varicella–zoster virus by immune adherence hemagglutination. Proc Soc Exp Biol Med 1976; 151: 762–5.
22. Williams V, Gershon A, Brunell PA. Serologic response to varicella–zoster membrane antigens measured by indirect immunofluorescence. J Infect Dis 1974; 130: 669–72.
23. Caunt EA, Shaw DG. Neutralization tests with varicella–zoster virus. J Hyg (Lond) 1969; 67: 343–52.
24. Schmidt NJ, Lennette EH, Woodie JD, Ho HH. Immunofluorescent staining in the laboratory diagnosis of varicella–zoster virus infections. J Lab Clin Med 1965; 66: 403–12.
25. Fleiss JL. Statistical methods for rales and proportions. New York: John Wiley, 1973:23–34.
26. Fisher RA. Statistical methods for research workers. 5th ed. Edinburgh: Oliver and Boyd, 1934:99–103.
27. Wallenstein S. A test for detection of clustering over time. Am J Epidemiol 1980; 111: 367–72.
28. Lichenstein PK, Heubi JE, Daugherty CC, et al. Grade I Reye's syndrome: a frequent cause of vomiting and liver dysfunction after varicella and upper-respiratory-tract infection. N Engl J Med 1983; 309: 133–9.
29. Asano Y, Albrecht P, Vujcic LK, Quinnan GV Jr, Kawakami K, Takahashi M. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays. Pediatrics 1983; 72: 291–4.
30. Asano Y, Yazaki T, Ito S, Isomura S, Takahashi M. Contact infection from live varicella vaccine recipients. Lancet 1976; 1: 965.
31. Feldman S, Hughes WT, Daniel CB. Varicella in children with cancer: seventy-seven cases. Pediatrics 1975; 56: 388–97.
32. Brunell PA. Fetal and neonatal varicella–zoster infections. Semin Perinatol 1983; 7: 47–56.